The Lithium Tremor That Means Toxicity, Not a Side Effect
The PMHNP boards love the tremor question because most students treat “tremor” as one thing. It isn’t. The trap is handing you a patient on lithium with a tremor and seeing whether you reassure them or panic appropriately. A new coarse, slow tremor on lithium is a toxicity flag — not a benign side effect — and it changes the whole management. Sort every tremor by when it appears and the question answers itself.
Sort by timing: rest vs. action
The single discriminator is whether the tremor shows up at rest or with movement.
- Resting tremor — present at rest, quiets with action. This is drug-induced parkinsonism, classically from dopamine blockers (antipsychotics). The move is a medication review of the antipsychotic.
- Postural/action tremor — appears when the limb is held against gravity or moving. This is the lithium bucket, plus valproate, essential tremor, and physiologic/anxiety tremor.
Get that split first. It decides everything downstream.
The benign lithium tremor — but verify
A fine postural/action tremor on lithium is common and often benign. That’s true. But “often benign” is not “ignore it.” Before you reassure the patient, check a lithium level — because the next paragraph is the reason.
The red flag
Here’s the finding the boards are testing: a NEW COARSE, SLOW action tremor on lithium = lithium toxicity until proven otherwise.
Fine and longstanding is one thing. New, coarse, and slow is a different animal. When you see it:
- Hold the dose
- Draw a STAT lithium level
- Assess the toxicity cluster: GI upset and vomiting, ataxia, dysarthria, confusion, hyperreflexia — progressing to seizures and coma at the severe end
The coarse tremor travels with that neuro-GI cluster. That’s what separates it from the benign fine tremor that travels alone.
What the numbers mean — and don’t
Therapeutic lithium is roughly 0.6–1.2 mEq/L. A level >1.5 signals toxicity; >2.0 is generally moderate-to-severe concern.
But don’t anchor to the number alone. Clinical severity depends on symptoms, chronicity, renal function, age, and neurologic findings. A chronically toxic older adult with poor renal clearance can be very sick at a level that looks only modestly elevated. Treat the patient and the picture, not just the lab value.
Treating the action tremor (when it’s NOT toxicity)
For an action/postural tremor that isn’t a toxicity signal — lithium fine tremor, valproate tremor, essential tremor, physiologic/anxiety tremor — the answer is propranolol and/or dose reduction.
The mirror-logic traps
This is where the exam scores points off reflexes. Keep these straight:
- Propranolol is for action tremor, NOT parkinsonian rest tremor. Don’t beta-block a resting tremor and expect a fix.
- Anticholinergics are for parkinsonism and dystonia, NOT akathisia. Different problem, different drug.
And one more clean-up: AIMS is a dyskinesia screening tool — it’s not the trigger here. The trigger for the lithium tremor is med and level review, not a dyskinesia scale.
Why this is easy to miss
“Tremor on lithium” pattern-matches to “expected side effect, reassure,” and most of the time that’s even right. The boards build the question around the exception — the new, coarse, slow tremor riding with ataxia and dysarthria — to see if you’ll reflexively reassure a toxic patient. Read the quality and the company it keeps, not just the word “tremor.”
On the exam: new coarse, slow action tremor on lithium → hold the dose, STAT level, look for the ataxia/dysarthria/confusion cluster — that’s toxicity, not a side effect.
Meridian’s board-prep course drills the timing-and-management discriminations the exam hides its answers inside — with worked cases and MSE video demos. Explore the board-prep course.